N Engl J Med October 2021 PMID 34449185

Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk.

Marco Valgimigli, Enrico Frigoli, Dik Heg, Jan Tijssen, Peter Jüni, Pascal Vranckx, Yukio Ozaki, Marie-Claude Morice, Bernard Chevalier, Yoshinobu Onuma, Stephan Windecker, Pim A L Tonino, Marco Roffi, Maciej Lesiak, Felix Mahfoud

Full text PDF Download social card

Mentions

222

Peak: 61 in Aug 2021

across 5 sources since Aug 2021

Extended reach

503,747

potential audience

Total likes

483

Video views

Mentions per month

Aug 2021 – Mar 2024

Where it's discussed

X / Twitter195 posts
News16 articles
Facebook6 posts
Blogs3 articles
YouTube2 videos

AI synopsis

What people are saying

Several discussions highlight key aspects of the article, with participants referencing trials like MASTER DAPT to underline their points. For example, one participant notes, 'Safety of the latest generation drug-eluting stents requires shorter duration DAPT,' while another emphasizes, 'One month of DAPT was noninferior to > two additional months.' The use of phrases like 'game changer' and 'less is more' conveys a tone of excitement and highlights the importance of adjusting treatment strategies based on the findings, contributing to a strong overall sentiment.

AgreementModerate agreement

The overall response indicates a moderate level of agreement with the findings of the article, showcased by many participants discussing the appropriateness of shortened therapy durations.

InterestHigh interest

There is a high interest in the topic as participants are actively discussing the implications of the study and its relevance to clinical practice.

EngagementHigh engagement

Many posts demonstrate deep engagement, citing specific studies and asking nuanced questions regarding treatment protocols, which reflects a strong investment in the discussion.

ImpactHigh impact

Participants perceive the publication as having a significant impact on current practices in cardiology, particularly in managing patients at high risk of bleeding.

Abstract in brief

The study investigates the duration of dual antiplatelet therapy in patients at high bleeding risk following the implantation of a drug-eluting stent.
After one month, patients were randomly assigned to either discontinue the therapy (abbreviated group) or continue for an additional two months (standard therapy).
The results showed that abbreviated therapy was noninferior in terms of net adverse clinical events and major adverse cardiac/cerebral events, and superior in reducing major or clinically relevant nonmajor bleeding.

Read the full abstract

All mentions

Exploring Dual Antiplatelet Therapy and Statin Side Effects in Cardiology

This week, John Mandrola MD discusses dual antiplatelet therapy after PCI, the side effects of statins, and considerations in HF care. The analysis emphasizes that many reported statin side effects may be linked to the…

Medscape · Mar 27, 2024 30 views

Evaluating Antiplatelet Therapy Duration in High Bleeding Risk Patients

This week's podcast discusses the importance of dual antiplatelet therapy duration for patients at high bleeding risk after drug-eluting stent placement. The study explores abbreviated therapy effectiveness compared to…

Medscape · Mar 27, 2024 15 views

Angela

@Angela_A3984 · X

RT @WiegerKaptein: Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk | NEJM https://t.co/EvnKv1A1nw

Sep 5, 2023 · 1 share · 29 followers View post →

Bernardo Vidal Pimentel

@BVidalPimentel · X

@PharmDFarmD From my IM generalist perspective: » Short-term DAT almost always better, definitely if higher bleeding risk eg >75y - MASTER DAPT https://t.co/Wl6IALIqRs & others » When monotherapy, clopidogrel almost always better - HOST-EXAM https://t.co/GxoZMcV8LK & now this MA

Jul 5, 2023 · 1 like · 287 followers View post →

Verónica Alexandra Alemán Iñiguez

@Veroalemanin · X

RT @javier20ch: ¿Por cuánto tiempo dejamos TAPD

May 3, 2023 · 58 shares · 131 followers View post →

Itchaya Kongmee

@ItchayaKongmee · X

RT @javier20ch: ¿Por cuánto tiempo dejamos TAPD

May 2, 2023 · 58 shares · 15 followers View post →

Nadia Rodríguez

@americadoc96 · X

RT @javier20ch: ¿Por cuánto tiempo dejamos TAPD

May 2, 2023 · 58 shares · 206 followers View post →

Maria Chapoñan Lorza

@Pumyaya19 · X

RT @javier20ch: ¿Por cuánto tiempo dejamos TAPD

Apr 30, 2023 · 58 shares · 203 followers View post →

Nahir Betzabeth

@Nahir3hen · X

RT @javier20ch: ¿Por cuánto tiempo dejamos TAPD

Apr 30, 2023 · 58 shares · 153 followers View post →

Zenen Rua

@ZenenRua · X

RT @javier20ch: ¿Por cuánto tiempo dejamos TAPD

Apr 30, 2023 · 58 shares · 54 followers View post →

Tymaria Stallworth

@AlRaJeLLC · X

RT @javier20ch: ¿Por cuánto tiempo dejamos TAPD

Apr 29, 2023 · 58 shares · 41 followers View post →

Gabriel Paredes, MD, FACC, FSSC

@gnparedes · X

RT @javier20ch: ¿Por cuánto tiempo dejamos TAPD

Apr 29, 2023 · 58 shares · 362 followers View post →

Enrique Araujo

@EnriqueA2612 · X

RT @javier20ch: ¿Por cuánto tiempo dejamos TAPD

Apr 29, 2023 · 58 shares · 4 followers View post →

Wagner Paul

@gzwagner · X

RT @javier20ch: ¿Por cuánto tiempo dejamos TAPD

Apr 29, 2023 · 58 shares · 160 followers View post →

Nathaly Acosta

@NathalyAcoosta · X

RT @javier20ch: ¿Por cuánto tiempo dejamos TAPD

Apr 29, 2023 · 58 shares · 536 followers View post →

Dr. Luis González

@drluisglezp · X

RT @javier20ch: ¿Por cuánto tiempo dejamos TAPD

Apr 29, 2023 · 58 shares · 225 followers View post →

Carito Zumaeta

@carilisszc1 · X

RT @javier20ch: ¿Por cuánto tiempo dejamos TAPD

Apr 29, 2023 · 58 shares · 68 followers View post →

FRANCIS DIAZ

@FRANCIS31737250 · X

RT @javier20ch: ¿Por cuánto tiempo dejamos TAPD

Apr 29, 2023 · 58 shares · 147 followers View post →

esmerlin ignacio

@esmerlin8505 · X

RT @javier20ch: ¿Por cuánto tiempo dejamos TAPD

Apr 29, 2023 · 58 shares · 182 followers View post →

HUGO COLOMBO MD

@HCOLOMBO1958 · X

RT @javier20ch: ¿Por cuánto tiempo dejamos TAPD

Apr 29, 2023 · 58 shares · 1,118 followers View post →

Dra Karla

@KarlaPoot4 · X

RT @javier20ch: ¿Por cuánto tiempo dejamos TAPD

Apr 29, 2023 · 58 shares · 82 followers View post →

Nicolas D. Santoyo S

@NicolasSantoyoS · X

RT @javier20ch: ¿Por cuánto tiempo dejamos TAPD

Apr 29, 2023 · 58 shares · 547 followers View post →

Dr. W.Roque

@WilfredoRoque7 · X

RT @javier20ch: ¿Por cuánto tiempo dejamos TAPD

Apr 29, 2023 · 58 shares · 110 followers View post →

@Esteban80856546 · X

RT @javier20ch: ¿Por cuánto tiempo dejamos TAPD

Apr 29, 2023 · 58 shares · 4 followers View post →

@napat_isara · X

RT @javier20ch: ¿Por cuánto tiempo dejamos TAPD

Apr 29, 2023 · 58 shares · 135 followers View post →

Orlando RPN

@OrlandoRPN · X

RT @javier20ch: ¿Por cuánto tiempo dejamos TAPD

Apr 29, 2023 · 58 shares · 93,354 followers View post →

Rayo

@RayoFR7 · X

RT @javier20ch: ¿Por cuánto tiempo dejamos TAPD

Apr 29, 2023 · 58 shares · 1,929 followers View post →

Motte

@AlvaradomotteA · X

RT @javier20ch: ¿Por cuánto tiempo dejamos TAPD

Apr 29, 2023 · 58 shares · 500 followers View post →

Carlos F. Matute-Martínez

@Felipe_Matute · X

Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk | NEJM https://t.co/ES01UeYBF7

Apr 29, 2023 · 213 followers View post →

José Llumiquinga Mar

@etsajose · X

RT @javier20ch: ¿Por cuánto tiempo dejamos TAPD

Apr 29, 2023 · 58 shares · 190 followers View post →

Jesus Salvador Sanchez Diaz

@JesusSanchez148 · X

RT @javier20ch: ¿Por cuánto tiempo dejamos TAPD

Apr 29, 2023 · 58 shares · 6,101 followers View post →

HCB

@HansCruzB · X

RT @javier20ch: ¿Por cuánto tiempo dejamos TAPD

Apr 29, 2023 · 58 shares · 385 followers View post →

Dr. Osmar Perez S.

@osmarperse · X

RT @javier20ch: ¿Por cuánto tiempo dejamos TAPD

Apr 29, 2023 · 58 shares · 2,455 followers View post →

Dr. Manuel Mendez

@manumenfer · X

RT @javier20ch: ¿Por cuánto tiempo dejamos TAPD

Apr 29, 2023 · 58 shares · 213 followers View post →

maldinilin

@maldinilin · X

RT @javier20ch: ¿Por cuánto tiempo dejamos TAPD

Apr 29, 2023 · 58 shares · 98 followers View post →

Juan

@Juan81849119 · X

RT @javier20ch: ¿Por cuánto tiempo dejamos TAPD

Apr 29, 2023 · 58 shares · 35 followers View post →

Javi

@javier_jex · X

RT @javier20ch: ¿Por cuánto tiempo dejamos TAPD

Apr 29, 2023 · 58 shares · 161 followers View post →

Philip J Fry

@miocardiocit · X

RT @javier20ch: ¿Por cuánto tiempo dejamos TAPD

Apr 29, 2023 · 58 shares · 37 followers View post →

Juan Carlos Obaya

@jcobaya69 · X

RT @javier20ch: ¿Por cuánto tiempo dejamos TAPD

Apr 29, 2023 · 58 shares · 857 followers View post →

D.J; Romero. ®

@Dr_DJRomero · X

RT @javier20ch: ¿Por cuánto tiempo dejamos TAPD

Apr 29, 2023 · 58 shares · 428 followers View post →

irene rilo

@irilomiranda · X

RT @javier20ch: ¿Por cuánto tiempo dejamos TAPD

Apr 29, 2023 · 58 shares · 513 followers View post →

Kevs

@Kevs_518 · X

RT @javier20ch: ¿Por cuánto tiempo dejamos TAPD

Apr 29, 2023 · 58 shares · 16 followers View post →

Alvaro Glez Franco

@alvarogfranco · X

RT @javier20ch: ¿Por cuánto tiempo dejamos TAPD

Apr 29, 2023 · 58 shares · 727 followers View post →

Ana Beltran Sanchez

@AnaBeltranSanc1 · X

RT @javier20ch: ¿Por cuánto tiempo dejamos TAPD

Apr 29, 2023 · 58 shares · 614 followers View post →

Adrian España L

@Adrian25L · X

RT @javier20ch: ¿Por cuánto tiempo dejamos TAPD

Apr 29, 2023 · 58 shares · 33 followers View post →

Paula Janet

@dueas_janet · X

RT @javier20ch: ¿Por cuánto tiempo dejamos TAPD

Apr 29, 2023 · 58 shares · 123 followers View post →

Juank_More

@JuanC_More · X

RT @javier20ch: ¿Por cuánto tiempo dejamos TAPD

Apr 29, 2023 · 58 shares · 248 followers View post →

Dr Coronario

@Drjulio_cardio · X

RT @javier20ch: ¿Por cuánto tiempo dejamos TAPD

Apr 29, 2023 · 58 shares · 280 followers View post →

Oscar Aspiazu Segovia. MD. ESP. MFYC| MsC.MPH

@opolito8514 · X

RT @javier20ch: ¿Por cuánto tiempo dejamos TAPD

Apr 28, 2023 · 58 shares · 283 followers View post →

Cynthia Alcantar

@Cynthia66493008 · X

RT @javier20ch: ¿Por cuánto tiempo dejamos TAPD

Apr 28, 2023 · 58 shares · 35 followers View post →

Yacir Almeida

@Dryaciralmeida · X

RT @javier20ch: ¿Por cuánto tiempo dejamos TAPD

Apr 28, 2023 · 58 shares · 60 followers View post →

César Alejandro

@CesarAlex84 · X

RT @javier20ch: ¿Por cuánto tiempo dejamos TAPD

Apr 28, 2023 · 58 shares · 76 followers View post →

Dr. FEVI

@javier20ch · X

¿Por cuánto tiempo dejamos TAPD

Apr 28, 2023 · 193 likes · 58 shares · 13,508 followers View post →

John Mannisi MD

@JMannisi · X

Safety of latest generation drug eluding coronary stents require shorter duration DAPT. For patients at high risk of bleeding 30 days DAPT non-inferior to 90 days https://t.co/WSSNI80xmM

Dec 2, 2022 · 1,848 followers View post →

Martin F Casey, MD MPH

@mfcasey · X

@blondemedSJW How recent was the stent? Pretty good evidence that at least one antiplatelet can be peeled back after 1 month… https://t.co/pmmum1AcLo

Nov 5, 2022 · 7 likes · 120 followers View post →

Jakub Podolec MD

@JakubPodolecMD · X

@SABOURETCardio https://t.co/aU4k6NTpkG

Oct 13, 2022 · 1 like · 61 followers View post →

Carolina Manzur

@CarolinaManzurB · X

#ESCCongress Guidelines in Practice: dual antiplatelet therapy (DAPT): a roller coaster ride

Aug 26, 2022 · 695 followers View post →

SCCP

@SCCP2020 · X

MASTER DAPT: Dual Antiplatelet Therapy After PCI in Patients at High Bleeding Risk | VuMedi https://t.co/qfW0aBh8Of via @vumedi

Aug 16, 2022 · 1 like · 2,197 followers View post →

Varun Victor

@Dr_VarunVictor · X

RT @krychtiukmd: MASTER-DAPT: >4000 ACS/CCS patients at high bleeding risk 1 month after an Ultimaster biodegradable stent, randomized t…

Apr 12, 2022 · 28 shares · 70 followers View post →

UninorteSalud

@UninorteSalud · X

Club de Revista: Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk https://t.co/tIMzz463fb

Apr 6, 2022 · 1,430 followers View post →

鯵ゼミ_Journal Club

@AJSR_since2005 · X

#082 Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk N Engl J Med 2021;385:1643-55. MASTER DAPT試験出血高リスク患者のPCI後のDAPT期間を1ヶ月とするのは、少なくとも3ヶ月以上とする場合と比較して、心臓・脳イベント発生は非劣性、出血イベントの発生率は低くした

Feb 26, 2022 · 6 followers View post →

Marco Valgimigli

@vlgmrc · X

RT @HFHIntMedRes: We have an exciting #JournalClub tomorrow presented by Dr. Batool Shukr (PGY3) and Dr. Firas Askar (PGY2) discussing DAPT…

Feb 16, 2022 · 1 share · 2,012 followers View post →

Henry Ford Hospital Internal Medicine Residency

@HFHIntMedRes · X

Feb 15, 2022 · 15 likes · 1 share · 3,551 followers View post →

John Mannisi MD

@JMannisi · X

Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk | NEJM https://t.co/cjMFMPambh Less is more-One month of DAPT in this cohort non-inferior to 3 months DAPT but with significantly less bleeding

Jan 18, 2022 · 1,848 followers View post →

Pablo Barroeta

@Padabadu · X

RT @almucastro01: MASTER DAPT: En pacientes de alto riesgo hemorragico, la doble antiagregación solo por 1 mes asegura: Igual eficacia en…

Dec 21, 2021 · 29 shares · 227 followers View post →

Adenosina

@Adenosina11 · X

RT @Dr__ELE: Comparación entre terapia dual antiplaquetaria 1 mes contra 2 meses posterior a colocación de stent liberador de fármaco, en c…

Dec 20, 2021 · 1 share · 4,699 followers View post →

Dr. L

@Dr__ELE · X

Comparación entre terapia dual antiplaquetaria 1 mes contra 2 meses posterior a colocación de stent liberador de fármaco, en cardiopatia isquemica 1 mes demostró no inferioridad en eventos tromboticos y si menor tasa de hemorragias DOI: 10.1056/NEJMoa2108749 https://t.co/Mir1H9MySU

Dec 20, 2021 · 2 likes · 1 share · 233 followers View post →

Bibliosaude

@Bibliosaude · X

Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk https://t.co/ASFitHzQHB #PublicaSergas #CHUVI

Dec 9, 2021 · 1,878 followers View post →

Residencia de Cardiología Hospital Cosme Argerich

@ArgerichCardio · X

El día 14-09 la Dra @cecemolina

Nov 23, 2021 · 5 likes · 2 shares · 714 followers View post →

ときヲ

@toki_wo_koe · X

Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk | NEJM https://t.co/5P8uYkzIUX

Nov 16, 2021 · 2 likes · 2,587 followers View post →

Antonio Manteca

@amango30 · X

RT @RevistaMFSamfyc: Terapia antiplaquetaria doble tras intervención coronaria percutánea en pacientes con alto riesgo de sangrado https://…

Nov 16, 2021 · 1 share · 138 followers View post →

Adams CardioMD

@AdamsCardioMD · X

Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk | NEJM https://t.co/V20cSM6IXK

Nov 9, 2021 · 608 followers View post →

Revista MFAndalucia

@RevistaMFSamfyc · X

Terapia antiplaquetaria doble tras intervención coronaria percutánea en pacientes con alto riesgo de sangrado https://t.co/TovNeTOF32 PMID 34449185

Nov 9, 2021 · 1 share · 723 followers View post →

Steve-o

@ssteeeve · X

RT @tadeclinicagem: REDUZ O DAPT Stent farmacológico é um avanço da cardiologia mas ainda há incertezas: qual o tempo ideal de dupla tera…

Nov 8, 2021 · 1 share · 94 followers View post →

Lorenzo Bertomeu

@BertomeuLorenzo · X

RT @almucastro01: MASTER DAPT: En pacientes de alto riesgo hemorragico, la doble antiagregación solo por 1 mes asegura: Igual eficacia en…

Nov 7, 2021 · 29 shares · 1,411 followers View post →

Tá de Clinicagem - TdC

@tadeclinicagem · X

REDUZ O DAPT Stent farmacológico é um avanço da cardiologia mas ainda há incertezas: qual o tempo ideal de dupla terapia antitrombótica (DAPT) em pacientes com alto risco de sangramento, após esse stent? O trial MASTER DAPT veio pra ajudar nessa questão https://t.co/wU4snOEFPt

Nov 7, 2021 · 3 likes · 1 share · 11,989 followers View post →

Javi Moreiras

@jmmoreiras · X

RT @almucastro01: MASTER DAPT: En pacientes de alto riesgo hemorragico, la doble antiagregación solo por 1 mes asegura: Igual eficacia en…

Nov 6, 2021 · 29 shares · 3,751 followers View post →

AHMED TAHA MOHAMED

@DESTAWY987 · X

RT @mirvatalasnag: #ESCCongress @escardio An honor to be regional PI & enroll in this landmark practice changing RCT Appreciate the proces…

Nov 6, 2021 · 42 shares · 24 followers View post →

esmerlin ignacio

@esmerlin8505 · X

RT @almucastro01: MASTER DAPT: En pacientes de alto riesgo hemorragico, la doble antiagregación solo por 1 mes asegura: Igual eficacia en…

Nov 4, 2021 · 29 shares · 182 followers View post →

СГАМ

@CGAM2016 · X

RT @almucastro01: MASTER DAPT: En pacientes de alto riesgo hemorragico, la doble antiagregación solo por 1 mes asegura: Igual eficacia en…

Nov 4, 2021 · 29 shares · 235 followers View post →

David Cabestrero Alonso

@DAVIDCABESTRERO · X

RT @almucastro01: MASTER DAPT: En pacientes de alto riesgo hemorragico, la doble antiagregación solo por 1 mes asegura: Igual eficacia en…

Nov 4, 2021 · 29 shares · 424 followers View post →

Jose Seijas Amigo

@AmigoSeijas · X

RT @almucastro01: MASTER DAPT: En pacientes de alto riesgo hemorragico, la doble antiagregación solo por 1 mes asegura: Igual eficacia en…

Nov 4, 2021 · 29 shares · 351 followers View post →

Nefrologia Hospital Universitari Vall d'Hebron

@NefrologiaVH · X

RT @almucastro01: MASTER DAPT: En pacientes de alto riesgo hemorragico, la doble antiagregación solo por 1 mes asegura: Igual eficacia en…

Nov 4, 2021 · 29 shares · 1,126 followers View post →

Juan Pedro Romero

@JuanPedroRome20 · X

RT @almucastro01: MASTER DAPT: En pacientes de alto riesgo hemorragico, la doble antiagregación solo por 1 mes asegura: Igual eficacia en…

Nov 3, 2021 · 29 shares · 204 followers View post →

Diego R. Campos

@diegocamposfr · X

RT @almucastro01: MASTER DAPT: En pacientes de alto riesgo hemorragico, la doble antiagregación solo por 1 mes asegura: Igual eficacia en…

Nov 3, 2021 · 29 shares · 426 followers View post →

Carlos Peña Gil

@carlospenagil · X

RT @almucastro01: MASTER DAPT: En pacientes de alto riesgo hemorragico, la doble antiagregación solo por 1 mes asegura: Igual eficacia en…

Nov 3, 2021 · 29 shares · 1,803 followers View post →

Cardio-Primària

@catcardiocamfic · X

RT @almucastro01: MASTER DAPT: En pacientes de alto riesgo hemorragico, la doble antiagregación solo por 1 mes asegura: Igual eficacia en…

Nov 3, 2021 · 29 shares · 1,870 followers View post →

Josué Félix Córdova

@Noinvasivo · X

RT @almucastro01: MASTER DAPT: En pacientes de alto riesgo hemorragico, la doble antiagregación solo por 1 mes asegura: Igual eficacia en…

Nov 3, 2021 · 29 shares · 35 followers View post →

@ICOTEO · X

RT @almucastro01: MASTER DAPT: En pacientes de alto riesgo hemorragico, la doble antiagregación solo por 1 mes asegura: Igual eficacia en…

Nov 3, 2021 · 29 shares · 81 followers View post →

Manuel Gaxiola

@cardiogax · X

RT @almucastro01: MASTER DAPT: En pacientes de alto riesgo hemorragico, la doble antiagregación solo por 1 mes asegura: Igual eficacia en…

Nov 3, 2021 · 29 shares · 7,995 followers View post →

SCCM Texas Chapter

@SCCMTXChapter · X

RT @CCPharmacists: "One month of DAPT was noninferior to > 2 additional months w/ regard to occurrence of net adverse events & major advers…

Nov 3, 2021 · 1 share · 312 followers View post →

Eduardo Enriquez

@EnriquezEdwardo · X

RT @almucastro01: MASTER DAPT: En pacientes de alto riesgo hemorragico, la doble antiagregación solo por 1 mes asegura: Igual eficacia en…

Nov 3, 2021 · 29 shares · 762 followers View post →

Cardiologo Francisco Javier González Miranda

@cardiofjgm · X

RT @almucastro01: MASTER DAPT: En pacientes de alto riesgo hemorragico, la doble antiagregación solo por 1 mes asegura: Igual eficacia en…

Nov 3, 2021 · 29 shares · 183 followers View post →

Juan Carlos Elizalde:.

@JuanElizalde777 · X

RT @almucastro01: MASTER DAPT: En pacientes de alto riesgo hemorragico, la doble antiagregación solo por 1 mes asegura: Igual eficacia en…

Nov 3, 2021 · 29 shares · 2,372 followers View post →

Diana Domingo Valero

@Diana_DoVa · X

RT @almucastro01: MASTER DAPT: En pacientes de alto riesgo hemorragico, la doble antiagregación solo por 1 mes asegura: Igual eficacia en…

Nov 3, 2021 · 29 shares · 512 followers View post →

José Reyes Lara

@JReyesLara1 · X

RT @almucastro01: MASTER DAPT: En pacientes de alto riesgo hemorragico, la doble antiagregación solo por 1 mes asegura: Igual eficacia en…

Nov 3, 2021 · 29 shares · 162 followers View post →

Diego Félix Arroyo Moñino

@arroyomdf · X

RT @almucastro01: MASTER DAPT: En pacientes de alto riesgo hemorragico, la doble antiagregación solo por 1 mes asegura: Igual eficacia en…

Nov 3, 2021 · 29 shares · 69 followers View post →

Juan Carlos Obaya

@jcobaya69 · X

RT @almucastro01: MASTER DAPT: En pacientes de alto riesgo hemorragico, la doble antiagregación solo por 1 mes asegura: Igual eficacia en…

Nov 3, 2021 · 29 shares · 857 followers View post →

Almudena Castro Conde

@almucastro01 · X

Nov 3, 2021 · 92 likes · 29 shares · 16,056 followers View post →

Brice Nouthe MD

@BriceN35924934 · X

RT @HanCardiomd: MASTER DAPT trial One month of #DAPT was noninferior to the continuation of therapy for at least 2 additional months with…

Nov 3, 2021 · 9 shares · 306 followers View post →

Alexis Gomez-Anaya

@cardioalexis · X

RT @HanCardiomd: MASTER DAPT trial One month of #DAPT was noninferior to the continuation of therapy for at least 2 additional months with…

Nov 3, 2021 · 9 shares · 437 followers View post →

mahesoo

@LoDoCo2 · X

RT @HanCardiomd: MASTER DAPT trial One month of #DAPT was noninferior to the continuation of therapy for at least 2 additional months with…

Nov 3, 2021 · 9 shares · 55 followers View post →

Abdulrahman Arabi

@abdarabi · X

RT @HanCardiomd: MASTER DAPT trial One month of #DAPT was noninferior to the continuation of therapy for at least 2 additional months with…

Nov 2, 2021 · 9 shares · 239 followers View post →

Oscar Mendiz

@omendiz · X

RT @HanCardiomd: MASTER DAPT trial One month of #DAPT was noninferior to the continuation of therapy for at least 2 additional months with…

Nov 2, 2021 · 9 shares · 8,679 followers View post →

Umair Khalid

@Umair2017 · X

RT @HanCardiomd: MASTER DAPT trial One month of #DAPT was noninferior to the continuation of therapy for at least 2 additional months with…

Nov 2, 2021 · 9 shares · 4,017 followers View post →

Elliott Guerrero

@DoctorElliottBG · X

Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk https://t.co/Yq7RBlhWlf

Nov 2, 2021 · 43 followers View post →

Manu

@manolitov1 · X

RT @AnguitaMandly: Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk | NEJM https://t.co/UfW2A1dSQ0

Nov 2, 2021 · 1 share · 113 followers View post →

Professor M Z Khalil

@mzkhalil · X

Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk | NEJM One month of DAPT after PCI was noninferior to the continuation of therapy for at least 2 additional months... https://t.co/L37woLFRT1 https://t.co/msqXBDB7Os

Oct 30, 2021 · 2 likes · 2,867 followers View post →

Maria Queralt Gorgas

@qgorgas · X

Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk | NEJM https://t.co/0G61FP6pJc

Oct 30, 2021 · 2 likes · 1,468 followers View post →

John H. Randall

@JohnHRandall1 · X

RT @JohnHRandall1: Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk | NEJM https://t.co/DpHYEX0Dxr

Oct 30, 2021 · 1 share · 44 followers View post →

John H. Randall

@JohnHRandall1 · X

Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk | NEJM https://t.co/DpHYEX0Dxr

Oct 30, 2021 · 1 share · 44 followers View post →

Lucy Pollock

@lucypgeridoc · X

Less is OK: dropping back to single agent antiplatelet in high bleed risk pts 1/12 after PCI is OK and causes fewer bleeds. Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk | NEJM https://t.co/At1PQPGOeR

Oct 30, 2021 · 1 like · 4,787 followers View post →

Shane Jensen

@shane_jensen19 · X

RT @bryanacotton1: We are down to only 30-days with DAPT after stent?

Oct 28, 2021 · 8 shares · 708 followers View post →

Gabriel Yanes

@gabiyavi · X

RT @bryanacotton1: We are down to only 30-days with DAPT after stent?

Oct 28, 2021 · 8 shares · 565 followers View post →

John P. Davis, MD, FACS

@JPDMD3 · X

RT @bryanacotton1: We are down to only 30-days with DAPT after stent?

Oct 28, 2021 · 8 shares · 432 followers View post →

J. Alex Weston

@jaye_weston · X

RT @bryanacotton1: We are down to only 30-days with DAPT after stent?

Oct 28, 2021 · 8 shares · 3,116 followers View post →

Eduardo Anguita, MD, PhD

@AnguitaMandly · X

Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk | NEJM https://t.co/UfW2A1dSQ0

Oct 28, 2021 · 1 share · 791 followers View post →

Michael Ditillo

@mikeditillo · X

RT @bryanacotton1: We are down to only 30-days with DAPT after stent?

Oct 28, 2021 · 8 shares · 2,748 followers View post →

Jeff Nahmias MD MHPE FACS FCCM

@jnahmias1 · X

RT @bryanacotton1: We are down to only 30-days with DAPT after stent?

Oct 28, 2021 · 8 shares · 5,611 followers View post →

Sabrina Goddard

@okiesdg · X

RT @bryanacotton1: We are down to only 30-days with DAPT after stent?

Oct 27, 2021 · 8 shares · 336 followers View post →

Bryan Cotton

@bryanacotton1 · X

We are down to only 30-days with DAPT after stent?

Oct 27, 2021 · 23 likes · 8 shares · 5,037 followers View post →

Vivek Subbiah, MD

@VivekSubbiah · X

Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk | NEJM https://t.co/omjxU7TI4R

Oct 27, 2021 · 39,045 followers View post →

Med Peds Hospitalist

@medpedshosp · X

Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk | NEJM https://t.co/jZTi9v5EcX

Oct 27, 2021 · 14,250 followers View post →

ACCP Adult Med PRN

@accpamedprn · X

Please join us TOMORROW 10/20 for our 2⃣‼️ #amedprn journal clubs! Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis; DOI: 10.1056/NEJMoa2033400 Dual antiplatelet therapy after PCI in patients at high bleeding risk; DOI: 10.1056/NEJMoa2108749

Oct 19, 2021 · 1,448 followers View post →

Wieger Kaptein

@WiegerKaptein · X

Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk | NEJM https://t.co/EvnKv1A1nw

Oct 18, 2021 · 1 share · 137 followers View post →

CardiologyTalk

@CardiologyTalk · X

Podcast- Marco Valgimigli, MD- @vlgmrc #CantonalHospital #UniversityofItalianSwitzerland #CoronaryArteryDisease #Cardiology #Research -Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk. https://t.co/6VT6YRLXeG https://t.co/awEvHEfViN

Oct 4, 2021 · 721 followers View post →

Anna Giulia Pavon

@AnnaGiuliaPavon · X

RT @CardiologyTalk: Marco Valgimigli, MD- @vlgmrc #CantonalHospital #UniversityofItalianSwitzerland #CoronaryArteryDisease #Cardiology #Res…

Oct 1, 2021 · 3 shares · 1,125 followers View post →

Antonio Landi

@antoniolandii · X

RT @CardiologyTalk: Marco Valgimigli, MD- @vlgmrc #CantonalHospital #UniversityofItalianSwitzerland #CoronaryArteryDisease #Cardiology #Res…

Oct 1, 2021 · 3 shares · 101 followers View post →

Marco Valgimigli

@vlgmrc · X

RT @CardiologyTalk: Marco Valgimigli, MD- @vlgmrc #CantonalHospital #UniversityofItalianSwitzerland #CoronaryArteryDisease #Cardiology #Res…

Oct 1, 2021 · 3 shares · 2,012 followers View post →

CardiologyTalk

@CardiologyTalk · X

Marco Valgimigli, MD- @vlgmrc #CantonalHospital #UniversityofItalianSwitzerland #CoronaryArteryDisease #Cardiology #Research -Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk. https://t.co/q0YUj82d8R https://t.co/Ry0B3iCqin

Sep 30, 2021 · 4 likes · 3 shares · 721 followers View post →

تطوير مهنة الصيدلة

@pharmaksaorg · X

New post in Development of Pharmacy Channel: Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk https://t.co/xY2iMFHLLd https://t.co/UG1S1W2KuA

Sep 27, 2021 · 8,391 followers View post →

MedPub.io

@MedPubApp · X

Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk For more up-to-date medical headlines, visit https://t.co/8ugyCPRjur #MedicalNews #MedTwitter #MedEd https://t.co/paluvpSFrG

Sep 17, 2021 · 266 followers View post →

猫になりたい薬剤師

@Vannyamoto · X

Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk https://t.co/SDRQVfUml7

Sep 16, 2021 · 1,046 followers View post →

xxxichiroxxx_ID

@xxxichiroxxx_ID · X

Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk | NEJM https://t.co/ELsk2d9Lq2 1ヵ月間のDAPTは，有害臨床事象および主要な心臓or脳の有害事象発生は，2ヵ月間治療を継続した場合と比較して非劣性であった。また，短期治療では，出血イベントの発生率が低かった。

Sep 11, 2021 · 157 followers View post →

pinacol

@pinacol · X

【RCT】PCI後、出血リスクが高い患者へのDAPT1ヶ月での終了は、DAPTの最低2ヶ月間の追加と比較して、正味の有害臨床イベントおよび主要心脳血管イベントに関して非劣性であり、大出血や臨床的に重要な非大出血を減少させた。 #ペ読 https://t.co/vtlIhbkT6Y

Sep 4, 2021 · 1,615 followers View post →

Dorothée Faille

@DorotheeFaille · X

Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk (OAC, NSAIDs or SAIDs, previous bleeding, age ≥75, plt <100G/L), coagulation disorder, repeated Hb <11g/dL, recent transfusion, cancer, stroke or PRECISE-DAPT ≥25) @NEJM https://t.co/BOpchfbwMr https://t.co/LQ24LHxKMF

Sep 2, 2021 · 370 followers View post →

University of Illinois Department of Medicine

@UICDom · X

RT @UICIMChiefs: 1/9 Our UIC IM "Article of the Week" courtesy of @atwing7: "Dual Antiplatelet Therapy after PCI in Patients at High Blee…

Aug 30, 2021 · 2 shares · 1,953 followers View post →

Sociedad Venezolana de Cardiología

@CardiologiaSVC · X

RT @ernestocardio: Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk | NEJM https://t.co/uzubYtONmH @mencardio @torresv…

Aug 30, 2021 · 4 shares · 13,304 followers View post →

Aaysha Cader

@aayshacader · X

RT @CERC_CRO: About #MASTERDAPT

Aug 30, 2021 · 3 shares · 9,072 followers View post →

Phani K

@JustKrrish · X

RT @CERC_CRO: About #MASTERDAPT

Aug 30, 2021 · 3 shares · 93 followers View post →

chief

@alaide_chief · X

RT @CERC_CRO: About #MASTERDAPT

Aug 30, 2021 · 3 shares · 3,529 followers View post →

CERC_CRO

@CERC_CRO · X

About #MASTERDAPT

Aug 30, 2021 · 4 likes · 3 shares · 471 followers View post →

Conner Olsen (he/him)

@COlsenMD · X

RT @UICIMChiefs: 1/9 Our UIC IM "Article of the Week" courtesy of @atwing7: "Dual Antiplatelet Therapy after PCI in Patients at High Blee…

Aug 29, 2021 · 2 shares · 203 followers View post →

UIC IM Chiefs

@UICIMChiefs · X

1/9 Our UIC IM "Article of the Week" courtesy of @atwing7: "Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk" (NEJM, 8/28/2021) #UICIMFamily #internalmedicine #MedEd @UICDom @UIHealth

Aug 29, 2021 · 4 likes · 2 shares · 553 followers View post →

Maruan C Chabbar

@MaruanCarlos · X

RT @Drroxmehran: #MASTER-DAPT at #ESCCongress: In 4579 #HBR pts w/ BP ULTIMASTER SES, DAPT discont at 1 vs. ≥5 months post-PCI was: ✅Nonin…

Aug 29, 2021 · 34 shares · 1,499 followers View post →

Lluis Asmarats

@AsmaratsL · X

RT @Drroxmehran: #MASTER-DAPT at #ESCCongress: In 4579 #HBR pts w/ BP ULTIMASTER SES, DAPT discont at 1 vs. ≥5 months post-PCI was: ✅Nonin…

Aug 29, 2021 · 34 shares · 806 followers View post →

Emilia Martinez

@emartinezgmg · X

RT @ernestocardio: Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk | NEJM https://t.co/uzubYtONmH @mencardio @torresv…

Aug 29, 2021 · 4 shares · 1,010 followers View post →

Laura Goodliffe

@laura_goodliffe · X

RT @Drroxmehran: #MASTER-DAPT at #ESCCongress: In 4579 #HBR pts w/ BP ULTIMASTER SES, DAPT discont at 1 vs. ≥5 months post-PCI was: ✅Nonin…

Aug 29, 2021 · 34 shares · 561 followers View post →

Breathe In Courage, Breathe Out Fear

@ZenForceVets · X

Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk | NEJM - https://t.co/oYXUGhAZTA https://t.co/L5nI6uvbZL

Aug 29, 2021 · 848 followers View post →

Pastor Perez Santigosa

@pastorluisps · X

RT @Drroxmehran: #MASTER-DAPT at #ESCCongress: In 4579 #HBR pts w/ BP ULTIMASTER SES, DAPT discont at 1 vs. ≥5 months post-PCI was: ✅Nonin…

Aug 29, 2021 · 34 shares · 102 followers View post →

Igor Morr

@igormorr · X

RT @ernestocardio: Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk | NEJM https://t.co/uzubYtONmH @mencardio @torresv…

Aug 29, 2021 · 4 shares · 3,937 followers View post →

Juan Pablo Carrera, MD.

@olbaPnauJ2 · X

Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk | NEJM https://t.co/PP2a7Sitxo

Aug 28, 2021 · 424 followers View post →

Lempira Guevara Matheus

@Lguevaramath · X

RT @ernestocardio: Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk | NEJM https://t.co/uzubYtONmH @mencardio @torresv…

Aug 28, 2021 · 4 shares · 1,178 followers View post →

marsad

@MarioMarsad · X

RT @Drroxmehran: #MASTER-DAPT at #ESCCongress: In 4579 #HBR pts w/ BP ULTIMASTER SES, DAPT discont at 1 vs. ≥5 months post-PCI was: ✅Nonin…

Aug 28, 2021 · 34 shares · 231 followers View post →

Ignacio Cigalini

@ICigalini · X

RT @NicolaRyanI1: MASTER DAPT #ESCCongress Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk | NEJM https://t.co/l2NhF…

Aug 28, 2021 · 1 share · 1,064 followers View post →

Ernesto Rodríguez H

@ernestocardio · X

Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk | NEJM https://t.co/uzubYtONmH @mencardio @torresviera @drjarayg @jstragazue @recetario1 @Lguevaramath @emartinezgmg @jpcostabel @jjamaro @DrPontecarlosi @lugocastle @alemai32 @ramicule @jacardio @igormorr

Aug 28, 2021 · 3 likes · 4 shares · 2,214 followers View post →

Saahil Jumkhawala

@saahilaj · X

RT @Drroxmehran: #MASTER-DAPT at #ESCCongress: In 4579 #HBR pts w/ BP ULTIMASTER SES, DAPT discont at 1 vs. ≥5 months post-PCI was: ✅Nonin…

Aug 28, 2021 · 34 shares · 526 followers View post →

Eduardo A. Arias

@EduardoAArias1 · X

RT @Drroxmehran: #MASTER-DAPT at #ESCCongress: In 4579 #HBR pts w/ BP ULTIMASTER SES, DAPT discont at 1 vs. ≥5 months post-PCI was: ✅Nonin…

Aug 28, 2021 · 34 shares · 1,237 followers View post →

John A. Fry MD, FACC, FSCAI

@JohnAFryMD · X

Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk | NEJM https://t.co/nDkO5mO75T

Aug 28, 2021 · 715 followers View post →

the paper link

@the_paper_link · X

Trend new: Valgimigli M, ..., Master DAPT Investigators (N Engl J Med) __Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk__ https://t.co/mW4pz6J8TV

Aug 28, 2021 · 137 followers View post →

tanqueray catherine

@tanqueraycathe1 · X

RT @Drroxmehran: #MASTER-DAPT at #ESCCongress: In 4579 #HBR pts w/ BP ULTIMASTER SES, DAPT discont at 1 vs. ≥5 months post-PCI was: ✅Nonin…

Aug 28, 2021 · 34 shares · 60 followers View post →

Ana Viana Tejedor

@Ana_Viana_T · X

Aug 28, 2021 · 8 likes · 33,998 followers View post →

Lijalem A. Tema,MD

@LijalemAbera · X

RT @Drroxmehran: #MASTER-DAPT at #ESCCongress: In 4579 #HBR pts w/ BP ULTIMASTER SES, DAPT discont at 1 vs. ≥5 months post-PCI was: ✅Nonin…

Aug 28, 2021 · 34 shares · 356 followers View post →

Mohamed Hamedh MSc, MD

@mohamedhamedh2 · X

Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk | NEJM https://t.co/cyJQbllCt0

Aug 28, 2021 · 615 followers View post →

Dragica Paunovic

@PaunovicDragica · X

RT @Drroxmehran: #MASTER-DAPT at #ESCCongress: In 4579 #HBR pts w/ BP ULTIMASTER SES, DAPT discont at 1 vs. ≥5 months post-PCI was: ✅Nonin…

Aug 28, 2021 · 34 shares · 142 followers View post →

Scott Cameron

@2Scottish · X

Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk | NEJM. Ever refining antiplatelet therapy. https://t.co/FK7VxzaTsx

Aug 28, 2021 · 2,116 followers View post →

Julia Grapsa

@JGrapsa · X

RT @Drroxmehran: #MASTER-DAPT at #ESCCongress: In 4579 #HBR pts w/ BP ULTIMASTER SES, DAPT discont at 1 vs. ≥5 months post-PCI was: ✅Nonin…

Aug 28, 2021 · 34 shares · 17,072 followers View post →

Ramón López Palop

@ramonlopezpalop · X

RT @Drroxmehran: #MASTER-DAPT at #ESCCongress: In 4579 #HBR pts w/ BP ULTIMASTER SES, DAPT discont at 1 vs. ≥5 months post-PCI was: ✅Nonin…

Aug 28, 2021 · 34 shares · 2,120 followers View post →

Tebaldi Matteo

@Tebaldi_Matteo · X

Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk | NEJM https://t.co/id2RCBz0GG. Congratulation @vlgmrc!

Aug 28, 2021 · 2 likes · 1 share · 1,130 followers View post →

Lavinia Baciu

@ESC_Lavinia · X

RT @Drroxmehran: #MASTER-DAPT at #ESCCongress: In 4579 #HBR pts w/ BP ULTIMASTER SES, DAPT discont at 1 vs. ≥5 months post-PCI was: ✅Nonin…

Aug 28, 2021 · 34 shares · 2,400 followers View post →

CardioBeans

@CardioBeans · X

MASTER DAPT trial was just announced in #ESCCongress2021! 1-month DAPT after PCI in high bleeding risk patients met non-inferiority margins for NACE and MACCE and was associated with ⬇️ bleedings against standard DAPT. Results are out @NEJM https://t.co/nXaBZUCYlK https://t.co/EAhTg4Cpy3

Aug 28, 2021 · 2 likes · 104 followers View post →

Emanuele Gallinoro, MD, PhD

@EGallinoro · X

RT @Drroxmehran: #MASTER-DAPT at #ESCCongress: In 4579 #HBR pts w/ BP ULTIMASTER SES, DAPT discont at 1 vs. ≥5 months post-PCI was: ✅Nonin…

Aug 28, 2021 · 34 shares · 554 followers View post →

Jair Vázquez

@jairlevogiro · X

RT @Drroxmehran: #MASTER-DAPT at #ESCCongress: In 4579 #HBR pts w/ BP ULTIMASTER SES, DAPT discont at 1 vs. ≥5 months post-PCI was: ✅Nonin…

Aug 28, 2021 · 34 shares · 269 followers View post →

Emmanuel JOSEPH

@drpsyjoseph · X

https://t.co/wEHjjixqaH

Aug 28, 2021 · 178 followers View post →

Hector Ortiz Mendoza

@Hector_E_Ortiz · X

RT @Drroxmehran: #MASTER-DAPT at #ESCCongress: In 4579 #HBR pts w/ BP ULTIMASTER SES, DAPT discont at 1 vs. ≥5 months post-PCI was: ✅Nonin…

Aug 28, 2021 · 34 shares · 382 followers View post →

Dr. Michael Alexander

@MichaelAlexandp · X

Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk | NEJM https://t.co/3ugjdvoL8i

Aug 28, 2021 · 855 followers View post →

Professor Vijay Kunadian

@VijayKunadian · X

RT @Drroxmehran: #MASTER-DAPT at #ESCCongress: In 4579 #HBR pts w/ BP ULTIMASTER SES, DAPT discont at 1 vs. ≥5 months post-PCI was: ✅Nonin…

Aug 28, 2021 · 34 shares · 5,046 followers View post →

Tuğba Kemaloğlu Öz, A/Prof

@KemalogluOz · X

RT @Drroxmehran: #MASTER-DAPT at #ESCCongress: In 4579 #HBR pts w/ BP ULTIMASTER SES, DAPT discont at 1 vs. ≥5 months post-PCI was: ✅Nonin…

Aug 28, 2021 · 34 shares · 11,566 followers View post →

Elvis Amao Ruiz

@elvisjar · X

Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk | NEJM https://t.co/KPryVp42c9

Aug 28, 2021 · 255 followers View post →

Nicola Ryan

@NicolaRyanI1 · X

MASTER DAPT #ESCCongress Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk | NEJM https://t.co/l2NhFSnU4D @AsherElad @aayshacader @Ortega_Paz @hect2701 @ICigalini

Aug 28, 2021 · 2 likes · 1 share · 640 followers View post →

Sabato Sorrentino

@sorrentinounicz · X

Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk | NEJM https://t.co/ubmY1p4RmK

Aug 28, 2021 · 1 like · 380 followers View post →

Milica Aleksic

@drmilicaa · X

RT @Drroxmehran: #MASTER-DAPT at #ESCCongress: In 4579 #HBR pts w/ BP ULTIMASTER SES, DAPT discont at 1 vs. ≥5 months post-PCI was: ✅Nonin…

Aug 28, 2021 · 34 shares · 1,295 followers View post →

ian smith

@iansmit35516854 · X

RT @Drroxmehran: #MASTER-DAPT at #ESCCongress: In 4579 #HBR pts w/ BP ULTIMASTER SES, DAPT discont at 1 vs. ≥5 months post-PCI was: ✅Nonin…

Aug 28, 2021 · 34 shares · 110 followers View post →

Daniel Munhoz

@DMunhoz · X

RT @Drroxmehran: #MASTER-DAPT at #ESCCongress: In 4579 #HBR pts w/ BP ULTIMASTER SES, DAPT discont at 1 vs. ≥5 months post-PCI was: ✅Nonin…

Aug 28, 2021 · 34 shares · 373 followers View post →

Hiteshi KC Chauhan

@HiteshiKc · X

RT @Drroxmehran: #MASTER-DAPT at #ESCCongress: In 4579 #HBR pts w/ BP ULTIMASTER SES, DAPT discont at 1 vs. ≥5 months post-PCI was: ✅Nonin…

Aug 28, 2021 · 34 shares · 443 followers View post →

Luca Bergamaschi

@L_Bergamaschi · X

RT @Drroxmehran: #MASTER-DAPT at #ESCCongress: In 4579 #HBR pts w/ BP ULTIMASTER SES, DAPT discont at 1 vs. ≥5 months post-PCI was: ✅Nonin…

Aug 28, 2021 · 34 shares · 515 followers View post →

Jenny Shan

@JennyShanzz · X

RT @Drroxmehran: #MASTER-DAPT at #ESCCongress: In 4579 #HBR pts w/ BP ULTIMASTER SES, DAPT discont at 1 vs. ≥5 months post-PCI was: ✅Nonin…

Aug 28, 2021 · 34 shares · 123 followers View post →

Santiago Giraldo

@stalvinder · X

RT @Drroxmehran: #MASTER-DAPT at #ESCCongress: In 4579 #HBR pts w/ BP ULTIMASTER SES, DAPT discont at 1 vs. ≥5 months post-PCI was: ✅Nonin…

Aug 28, 2021 · 34 shares · 295 followers View post →

Christophe VdM

@ChristopheVdM · X

RT @Drroxmehran: #MASTER-DAPT at #ESCCongress: In 4579 #HBR pts w/ BP ULTIMASTER SES, DAPT discont at 1 vs. ≥5 months post-PCI was: ✅Nonin…

Aug 28, 2021 · 34 shares · 9 followers View post →

Rajinder thaploo

@drrajinder1984 · X

RT @Drroxmehran: #MASTER-DAPT at #ESCCongress: In 4579 #HBR pts w/ BP ULTIMASTER SES, DAPT discont at 1 vs. ≥5 months post-PCI was: ✅Nonin…

Aug 28, 2021 · 34 shares · 2,079 followers View post →

Şafak Sakallı

@sakall_safak · X

RT @Drroxmehran: #MASTER-DAPT at #ESCCongress: In 4579 #HBR pts w/ BP ULTIMASTER SES, DAPT discont at 1 vs. ≥5 months post-PCI was: ✅Nonin…

Aug 28, 2021 · 34 shares · 29 followers View post →

Victoria Delgado

@VDelgadoGarcia · X

RT @Drroxmehran: #MASTER-DAPT at #ESCCongress: In 4579 #HBR pts w/ BP ULTIMASTER SES, DAPT discont at 1 vs. ≥5 months post-PCI was: ✅Nonin…

Aug 28, 2021 · 34 shares · 11,783 followers View post →

Verena Götz

@VerenaEgger1 · X

RT @Drroxmehran: #MASTER-DAPT at #ESCCongress: In 4579 #HBR pts w/ BP ULTIMASTER SES, DAPT discont at 1 vs. ≥5 months post-PCI was: ✅Nonin…

Aug 28, 2021 · 34 shares · 88 followers View post →

Zainab Dakhil

@ZainabDakhil2 · X

RT @Drroxmehran: #MASTER-DAPT at #ESCCongress: In 4579 #HBR pts w/ BP ULTIMASTER SES, DAPT discont at 1 vs. ≥5 months post-PCI was: ✅Nonin…

Aug 28, 2021 · 34 shares · 1,585 followers View post →

Guillaume Bonnet

@guilbon · X

RT @Drroxmehran: #MASTER-DAPT at #ESCCongress: In 4579 #HBR pts w/ BP ULTIMASTER SES, DAPT discont at 1 vs. ≥5 months post-PCI was: ✅Nonin…

Aug 28, 2021 · 34 shares · 3,495 followers View post →

Dr Roxana Mehran

@Drroxmehran · X

Aug 28, 2021 · 103 likes · 34 shares · 24,232 followers View post →

Hospital Medicine Virtual Journal Club

@HMVJC · X

Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk https://t.co/6I3LNaxnep #medtwitter

Aug 28, 2021 · 631 followers View post →

Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk.

Mentions per month

Where it's discussed

What people are saying

Abstract in brief

Top posts

All mentions

Exploring Dual Antiplatelet Therapy and Statin Side Effects in Cardiology

Evaluating Antiplatelet Therapy Duration in High Bleeding Risk Patients